Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma

Blood Adv (2019) 3 (9): 1546–1552.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals